Kong Gwyneth, Chin Yip H, Lim Jieyu, Ng Cheng H, Kannan Shankar, Chong Bryan, Lin Chaoxing, Chan Kai E, Anand Vickram V, Lee Ethan C Z, Loong Shaun, Wong Zhen Y, Khoo Chin M, Muthiah Mark, Foo Roger, Dimitriadis Georgios K, Figtree Gemma A, Wang Yibin, Chan Mark, Chew Nicholas W S
Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
Obesity (Silver Spring). 2023 Mar;31(3):832-840. doi: 10.1002/oby.23658. Epub 2023 Feb 7.
With rising prevalence of hypertension and obesity, the effect of hypertension in obesity remains an important global issue. The prognosis of the US general population with obesity based on hypertension control was examined.
This study examined participants from the National Health and Nutrition Examination Survey between 1999 and 2018. Individuals with obesity were stratified into no hypertension, controlled hypertension, and uncontrolled hypertension. The study outcome was all-cause mortality. Cox regression of all-cause mortality was adjusted for age, sex, ethnicity, diabetes, and previous myocardial infarction.
Of 16,386 individuals with obesity, 53.1% had no hypertension, 24.7% had controlled hypertension, and 22.2% had uncontrolled hypertension. All-cause mortality was significantly higher in uncontrolled hypertension (17.1%), followed by controlled hypertension (14.8%) and no hypertension (4.0%). Uncontrolled hypertension had the highest mortality risk (hazard ratio [HR] 1.34, 95% CI: 1.13-1.59, p = 0.001), followed by controlled hypertension (HR 1.21, 95% CI: 1.10-1.34, p < 0.001), compared with no hypertension after adjustment. The excess mortality trend was more pronounced in females, those with diabetes, and those older than age 65 years.
The incremental mortality risk in controlled and uncontrolled hypertension, compared with the normotensive counterparts, irrespective of sex, age, and diabetes status, urges health care providers to optimize hypertension control and advocate weight loss to achieve better outcomes in obesity.
随着高血压和肥胖症患病率的上升,高血压在肥胖症中的影响仍是一个重要的全球性问题。本研究对美国普通肥胖人群基于高血压控制情况的预后进行了调查。
本研究调查了1999年至2018年期间参加美国国家健康与营养检查调查的参与者。肥胖个体被分为无高血压、高血压得到控制和高血压未得到控制三类。研究结局为全因死亡率。全因死亡率的Cox回归分析对年龄、性别、种族、糖尿病和既往心肌梗死进行了校正。
在16386名肥胖个体中,53.1%无高血压,24.7%高血压得到控制,22.2%高血压未得到控制。高血压未得到控制组的全因死亡率显著更高(17.1%),其次是高血压得到控制组(14.8%)和无高血压组(4.0%)。校正后,与无高血压组相比,高血压未得到控制组的死亡风险最高(风险比[HR]1.34,95%置信区间:1.13 - 1.59,p = 0.001),其次是高血压得到控制组(HR 1.21,95%置信区间:1.10 - 1.34,p < 0.001)。女性、糖尿病患者以及65岁以上人群的超额死亡趋势更为明显。
与血压正常者相比,无论性别、年龄和糖尿病状态如何,高血压得到控制和未得到控制时死亡风险均增加,这促使医疗保健提供者优化高血压控制并倡导减肥,以在肥胖人群中取得更好的结果。